Christian Behrenbruch
MD & Group CEO at Telix Pharmaceuticals Limited
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 7 months
- Director since
- 2026
7 months of board service in total across 1 board, counting each seat separately. Longest: Telix Pharmaceuticals Limited, 7 months.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 29, 2026 | Telix Pharmaceuticals Limited | Open-market purchase | +33,435 | $14.87 | $497,178 |
| Apr 28, 2026 | Telix Pharmaceuticals Limited | Open-market purchase | +34,500 | $14.48 | $499,560 |
Questions about Christian Behrenbruch
What boards is Christian Behrenbruch on?
Christian Behrenbruch sits on the board of Telix Pharmaceuticals Limited.
What company is Christian Behrenbruch the CEO of?
Christian Behrenbruch has been MD & Group CEO of Telix Pharmaceuticals Limited since March 2026.
How long has Christian Behrenbruch served on boards?
Our records show at least 7 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.